Chun Y. Wu

600 Tianhe Road
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Caregiving experiences and support challenges of older caregivers from the perspective of the digital divide: a qualitative study.

Caregiving experiences and support challenges of older caregivers from the perspective of the digital divide: a qualitative study.

Journal: Frontiers in public health
Published: January 28, 2026

The paracrine TAC1-TACR1 signaling promotes endothelial senescence and metastatic progression in neuroblastoma.

The paracrine TAC1-TACR1 signaling promotes endothelial senescence and metastatic progression in neuroblastoma.

Journal: Cancer letters
Published: November 20, 2025

GPNMB Drives Brain Metastasis by Sculpting a Pathologic Endothelial-Immune Interactome.

GPNMB Drives Brain Metastasis by Sculpting a Pathologic Endothelial-Immune Interactome.

Journal: Cancer discovery
Published: September 23, 2025

NMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and Malignancy.

NMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and Malignancy.

Journal: Cancer immunology research
Published: September 02, 2025

CBX3 confers ferroptosis resistance during blood-borne metastasis.

CBX3 confers ferroptosis resistance during blood-borne metastasis.

Journal: Journal of hematology & oncology
Published: August 21, 2025

The Tumor-to-Endothelial Transfer of FTO Promotes Vascular Remodeling and Metastasis in Nasopharyngeal Carcinoma.

The Tumor-to-Endothelial Transfer of FTO Promotes Vascular Remodeling and Metastasis in Nasopharyngeal Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 26, 2025

Reduced expression of UPF1 promotes tumor progression through stabilizing COX-2 mRNA in nasopharyngeal carcinoma.

Reduced expression of UPF1 promotes tumor progression through stabilizing COX-2 mRNA in nasopharyngeal carcinoma.

Journal: Frontiers in immunology
Published: April 25, 2025

Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA.

Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA.

Journal: Frontiers in immunology
Published: April 15, 2025

Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.

Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.

Journal: Cancer research
Published: January 20, 2025

Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis.

Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis.

Journal: Academic radiology
Published: March 15, 2024

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study.

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study.

Journal: Journal of hepatocellular carcinoma
Published: February 05, 2024

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC).

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC).

Journal: Journal of cancer research and clinical oncology
Published: November 20, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026